Kidney Health Research Collaborative, Department of Medicine, San Francisco Veterans Affairs Health Care System and University of California, San Francisco, CA, USA.
Department of Medicine, Division of Nephrology, University of California, 533 Parnassus Avenue, U404, Box 0532, San Francisco, CA, 94143, USA.
BMC Nephrol. 2021 Aug 30;22(1):296. doi: 10.1186/s12882-021-02508-6.
Novel urine biomarkers have enabled the characterization of kidney tubular dysfunction and injury among persons living with HIV, a population at an increased risk of kidney disease. Even though several urine biomarkers predict progressive kidney function decline, antiretroviral toxicity, and mortality in the setting of HIV infection, the relationships among the risk factors for chronic kidney disease (CKD) and urine biomarkers are unclear.
We assessed traditional and infection-related CKD risk factors and measured 14 urine biomarkers at baseline and at follow-up among women living with HIV in the Women's Interagency Health Study (WIHS). We then used simultaneously adjusted multivariable linear regression models to evaluate the associations of CKD risk factors with longitudinal changes in biomarker levels.
Of the 647 women living with HIV in this analysis, the majority (67%) were Black, the median age was 45 years and median follow-up time was 2.5 years. Each traditional and infection-related CKD risk factor was associated with a unique set of changes in urine biomarkers. For example, baseline hemoglobin a1c was associated with worse tubular injury (higher interleukin [IL]-18), proximal tubular reabsorptive dysfunction (higher α1-microglobulin), tubular reserve (lower uromodulin) and immune response to injury (higher chitinase-3-like protein-1 [YKL-40]). Furthermore, increasing hemoglobin a1c at follow-up was associated with further worsening of tubular injury (higher kidney injury molecule-1 [KIM-1] and IL-18), as well as higher YKL-40. HCV co-infection was associated with worsening proximal tubular reabsorptive dysfunction (higher β2-microglobulin [β2m]), and higher YKL-40, whereas HIV viremia was associated with worsening markers of tubular and glomerular injury (higher KIM-1 and albuminuria, respectively).
CKD risk factors are associated with unique patterns of biomarker changes among women living with HIV, suggesting that serial measurements of multiple biomarkers may help in detecting and monitoring kidney disease in this setting.
新型尿液生物标志物使人们能够描述艾滋病毒感染者的肾小管功能障碍和损伤,而艾滋病毒感染者患肾脏疾病的风险增加。尽管有几种尿液生物标志物可以预测艾滋病毒感染人群的肾功能进行性下降、抗逆转录病毒毒性和死亡率,但慢性肾脏病(CKD)的危险因素与尿液生物标志物之间的关系尚不清楚。
我们评估了传统和与感染相关的 CKD 危险因素,并在妇女健康研究(WIHS)中对感染艾滋病毒的妇女进行了基线和随访时的 14 种尿液生物标志物的测量。然后,我们使用同时调整的多变量线性回归模型来评估 CKD 危险因素与生物标志物水平纵向变化的关系。
在这项分析中,647 名感染艾滋病毒的妇女中,大多数(67%)为黑人,中位年龄为 45 岁,中位随访时间为 2.5 年。每个传统和与感染相关的 CKD 危险因素都与一组独特的尿液生物标志物变化相关。例如,基线糖化血红蛋白与肾小管损伤(更高的白细胞介素[IL]-18)、近端肾小管重吸收功能障碍(更高的α1-微球蛋白)、肾小管储备(更低的尿调蛋白)和损伤后的免疫反应(更高的几丁质酶-3 样蛋白-1 [YKL-40])有关。此外,随访时糖化血红蛋白的升高与肾小管损伤的进一步恶化(更高的肾脏损伤分子-1 [KIM-1]和 IL-18)以及更高的 YKL-40 有关。HCV 合并感染与近端肾小管重吸收功能障碍的恶化(更高的β2-微球蛋白[β2m])和更高的 YKL-40 有关,而 HIV 病毒血症与肾小管和肾小球损伤的标志物恶化有关(分别为 KIM-1 和蛋白尿)。
CKD 危险因素与艾滋病毒感染者的生物标志物变化模式有关,这表明连续测量多种生物标志物可能有助于在这种情况下检测和监测肾脏疾病。